Registered entities
Sillajen Biotherapeutics, Inc.
Reg. No. 261730046United States
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developing oncolytic immunotherapies for solid tumors, targeting cancer through diverse mechanisms
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |